1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antivirals Market Size Growth Rate by Type (2020-2025)
1.3.2 Generic
1.3.3 Branded
1.4 Market Segment by Application
1.4.1 Global Antivirals Market Share by Application (2020-2025)
1.4.2 Application I
1.4.3 HIV
1.4.4 Hepatitis
1.4.5 HSV
1.4.6 Influenza
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antivirals Market Size
2.1.1 Global Antivirals Revenue 2015-2025
2.1.2 Global Antivirals Sales 2015-2025
2.2 Antivirals Growth Rate by Regions
2.2.1 Global Antivirals Sales by Regions 2015-2019
2.2.2 Global Antivirals Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antivirals Sales by Manufacturers
3.1.1 Antivirals Sales by Manufacturers 2015-2019
3.1.2 Antivirals Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Antivirals Revenue by Manufacturers (2015-2019)
3.2.2 Antivirals Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Antivirals Market Concentration Ratio (CR5 and HHI)
3.3 Antivirals Price by Manufacturers
3.4 Key Manufacturers Antivirals Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antivirals Market
3.6 Key Manufacturers Antivirals Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Generic Sales and Revenue (2015-2019)
4.1.2 Branded Sales and Revenue (2015-2019)
4.2 Global Antivirals Sales Market Share by Type
4.3 Global Antivirals Revenue Market Share by Type
4.4 Antivirals Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antivirals Sales by Application
6 United States
6.1 United States Antivirals Breakdown Data by Company
6.2 United States Antivirals Breakdown Data by Type
6.3 United States Antivirals Breakdown Data by Application
7 European Union
7.1 European Union Antivirals Breakdown Data by Company
7.2 European Union Antivirals Breakdown Data by Type
7.3 European Union Antivirals Breakdown Data by Application
8 China
8.1 China Antivirals Breakdown Data by Company
8.2 China Antivirals Breakdown Data by Type
8.3 China Antivirals Breakdown Data by Application
9 Rest of World
9.1 Rest of World Antivirals Breakdown Data by Company
9.2 Rest of World Antivirals Breakdown Data by Type
9.3 Rest of World Antivirals Breakdown Data by Application
9.4 Rest of World Antivirals Breakdown Data by Countries
9.4.1 Rest of World Antivirals Sales by Countries
9.4.2 Rest of World Antivirals Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antivirals
10.1.4 Antivirals Product Introduction
10.1.5 Merck Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antivirals
10.2.4 Antivirals Product Introduction
10.2.5 Johnson & Johnson Recent Development
10.3 Teva Pharmaceutical Industries
10.3.1 Teva Pharmaceutical Industries Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antivirals
10.3.4 Antivirals Product Introduction
10.3.5 Teva Pharmaceutical Industries Recent Development
10.4 GSK
10.4.1 GSK Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antivirals
10.4.4 Antivirals Product Introduction
10.4.5 GSK Recent Development
10.5 Mylan
10.5.1 Mylan Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antivirals
10.5.4 Antivirals Product Introduction
10.5.5 Mylan Recent Development
10.6 Gilead Sciences
10.6.1 Gilead Sciences Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Antivirals
10.6.4 Antivirals Product Introduction
10.6.5 Gilead Sciences Recent Development
10.7 F. Hoffmann-La Roche
10.7.1 F. Hoffmann-La Roche Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Antivirals
10.7.4 Antivirals Product Introduction
10.7.5 F. Hoffmann-La Roche Recent Development
10.8 Bristol-Myers-Squibb
10.8.1 Bristol-Myers-Squibb Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Antivirals
10.8.4 Antivirals Product Introduction
10.8.5 Bristol-Myers-Squibb Recent Development
10.9 AbbVie
10.9.1 AbbVie Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Antivirals
10.9.4 Antivirals Product Introduction
10.9.5 AbbVie Recent Development
10.10 Aurobindo Pharma
10.10.1 Aurobindo Pharma Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Antivirals
10.10.4 Antivirals Product Introduction
10.10.5 Aurobindo Pharma Recent Development
10.11 Cipla
10.12 Dr Reddy\'s
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antivirals Sales Channels
11.2.2 Antivirals Distributors
11.3 Antivirals Customers
12 Market Forecast
12.1 Global Antivirals Sales and Revenue Forecast 2020-2025
12.2 Global Antivirals Sales Forecast by Type
12.3 Global Antivirals Sales Forecast by Application
12.4 Antivirals Forecast by Regions
12.4.1 Global Antivirals Sales Forecast by Regions 2020-2025
12.4.2 Global Antivirals Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
